American Vanguard Cuts 2026 Outlook After Q3 Sales Fall 9%

American Vanguard (NYSE:AVD) cut its 2026 revenue outlook to $500 million to $530 million, down from $530 million to $550 million, after third-quarter sales fell 9% to $108 million from $119 million a year earlier. The company also lowered its adjusted EBITDA forecast to $36 million to $40 million, from $44 million to $48 million previously.

The agricultural products maker reported third-quarter adjusted EBITDA of approximately break-even, a decline of $8.3 million from the prior-year quarter. Management nonetheless projects fourth-quarter net sales of roughly $166 million, up 10% year over year, and adjusted EBITDA of $21 million, up about 25%.

CEO Dak Kaye said difficult agricultural market conditions have kept distributors and retailers buying only as needed and holding lean inventories. He attributed the guidance reduction primarily to weaker-than-expected international results and the company's inability to raise prices quickly enough to offset higher fuel and raw material costs.

Every promise here came with a caveat. Kaye cautioned that the company still has substantial work to do to meet fourth-quarter expectations, and the comparison includes more than $11 million in upfront royalty income that lifted both sales and adjusted EBITDA in the fourth quarter of 2025. "I cannot say that it is all baked in," Kaye said in response to an analyst's question. "It is just not the way the business runs, the industry runs, especially here in the U.S."

What drove the international decline?

International sales fell 17% in the third quarter and 14% for the first nine months, CFO Matt Horwath said, attributing the drops primarily to poor weather in Latin America related to El Niño. Higher soil fumigant sales and growth in Ecuador partially offset the weakness.

The regional detail was uneven:

• Central America: drought on the Pacific side and excessive rain on the Atlantic side hurt business.
• Mexico: low crop prices and generic competition pressured sales and margins.
• Brazil: political uncertainty, higher copper prices and delayed purchasing decisions weakened sales.

U.S. crop and specialty sales each declined 2% in the quarter. For the first nine months, U.S. crop sales rose 3% and specialty sales increased 6%. Companywide nine-month sales fell 4% to $349 million.

Gross margin narrowed to 24.2% from 28.7% a year earlier. Horwath said manufacturing performance improved, but freight costs, higher raw material costs and lower fixed-cost leverage more than offset the gain. Freight alone reduced gross margin by approximately 250 basis points.

The margin story rests on costs the company does not fully control: fuel prices forced price increases that, by Kaye's own account, arrived too slowly to protect the quarter.

What savings and acquisitions deliver?

American Vanguard completed the closure of its Los Angeles manufacturing operation and shifted synthesis production to Axis, Alabama. Kaye said the move should save at least $4 million annually, with the third quarter marking the first full quarter of savings. A headquarters relocation to Irvine is expected to save approximately $500,000 a year.

The savings, however, were more than offset by rising transportation costs, Kaye said. The company is implementing price increases where possible to address higher fuel costs.

At quarter-end, American Vanguard acquired four U.S. brands and registrations from Syngenta for $9.5 million — $5 million paid upfront, $4.5 million due in a year — and signed a distribution agreement with Sipcam Agro. Management expects the additions to contribute $15 million to $20 million in annualized revenue over the next 12 months. The company plans to launch Duro LQ, a liquid corn insecticide, in the U.S. this quarter, and maintains a goal of 50 new product launches generating $100 million in annualized revenue by 2030.

The cash picture tightened at the covenant line. The company ended the quarter with $84 million in cash, up $40 million from the prior quarter on customer prepayments that rose 44% year over year. Total debt stood at $267.7 million; net debt was approximately $183.8 million. Gross leverage on the first-lien term loan covenant reached 6.5 times against a maximum of 6.7 times — a margin of two-tenths of a turn. Management expects leverage to decline by year-end based on fourth-quarter guidance and anticipated cash generation.

Kaye reiterated a target of an annualized sales run rate above $600 million by the second half of 2028, while prioritizing a return to a double-digit EBITDA margin as soon as possible.

A company two-tenths of a turn from its covenant ceiling is betting its recovery on a quarter its own chief executive declines to call baked in.